DUBLIN–(BUSINESS WIRE)–The “Agricultural Biotechnology Market Research Report: By Technology (Genome Editing, DNA Sequencing, RNAi, Synthetic Biology, Biochip), Product (Transgenic Seeds, Crop Protection Products) – Global Industry Analysis and Growth Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering.
Global agricultural biotechnology market revenue will grow from $39,565.6 million in 2020 to $106,870.0 million by 2030, at a 10.7% CAGR between 2021 and 2030.
This will be due to the burgeoning demand for food, which has already been putting immense pressure on the agrarian community for centuries.
In addition, with the expansion of human settlements, the availability of farmlands is reducing, which is why farmers are under intense pressure to make the most of what they have. This is fueling the agricultural biotechnology market advance by leading to the rising adoption of enhanced technologies for crop cultivation. Moreover, the rising disposable income of people is allowing them to purchase genetically modified (GM) crops, which are expensive.
The COVID-19 pandemic has significantly affected the agricultural biotechnology market due to the lockdowns and movement restrictions around the world. On account of the reduced demand for biofuel, its and its feedstock’s prices have dwindled. However, the demand for GM crops was not affected much, as the requirement for food for the 7.7 billion people on earth remained stable.
In the coming years, the genome editing category, under the technology segment, will continue to generate the highest agricultural biotechnology market revenue. With this technology, healthier crops, which stay unaffected by droughts and floods and are resistant to insects, can be produced. As a result, the genome editing technology is being extensively researched upon and adopted by the agrarian community.
The fastest growth in the agricultural biotechnology market is predicted to be seen in Asia-Pacific (APAC) during this decade. Being the most-populated region, APAC is witnessing the adoption of modern techniques for the augmentation of the agricultural yield.
Moreover, extensive research and development (R&D) has led to the rapid uptake of GM crops in the region, which are increasingly receiving approvals from regulatory authorities.
Competitive Landscape
- Benchmarking of Key Players Based on Product Offering
- Recent Strategic Developments of Key Players
- Mergers and Acquisitions
- Product Launches and Approvals
- Partnerships
- Other Developments
The most-significant players in the global agricultural biotechnology market are
- Syngenta AG
- DuPont de Nemours Inc.
- Performance Plants Inc.
- Certis USA LLC
- Bayer AG
- BASF SE
- Vilmorin & Cie
- Evogene Ltd.
- ADAMA Agricultural Solutions Ltd.
- KWS SAAT SE & Co. KGaA
- Global Bio-Chem Technology Group Company Limited
- Novozymes A/S
Key Topics Covered:
Chapter 1. Research Background
Chapter 2. Research Methodology
Chapter 3. Executive Summary
Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 By Technology
- Genome editing
- DNA sequencing
- RNAi
- Synthetic biology
- Biochip
4.1.2 By Product
- Transgenic seeds
- Soybean
- Maize
- Cotton
- Fruits and vegetables
Crop protection products
- Biopesticides
- Biostimulants
4.2 Market Dynamics
4.2.1 Trends
- Increasing adoption of biofuels
4.2.2 Drivers
- Growing population base
- Rising per capita income
- Surging demand for transgenic crops
- Impact analysis of drivers on market forecast
4.2.3 Restraints
- Stringent regulations pertaining to the registration of GM products
- The use of the terminator seed technology
- Restriction on GM crops in Europe
- Impact analysis of restraints on market forecast
4.2.4 Opportunities
- Majority of GM crop cultivation in developing economies
4.3 Porter’s Five Forces Analysis
4.4 Impact of Covid-19
4.5 Major Targeted Genes
For more information about this report visit https://www.researchandmarkets.com/r/sfrpq7
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900